Inflamatory state and cardiovascular risk control: Towards a new paradigm

• Anti-inflammatory Therapies for Cardiovascular Disease: Signaling Pathways and Mechanisms

  Sergio Martínez-Hervás, Herminia González-Navarro

  Rev Esp Cardiol. 2019;72:767-73

• Potential Therapeutic Value of Interleukin 1b-targeted Strategies in Atherosclerotic Cardiovascular Disease

  Vanesa Viana-Huete, José J. Fuster

  Rev Esp Cardiol. 2019;72:760-6